Supracor laser-assisted in situ keratomileusis for the correction of presbyopia efficacy and safety

Background and aim Presbyopia is a refractive disorder associated with aging, marked by the gradual loss of the eye’s capacity to focus on close-range objects, typically beginning between 40 and 45 years of age. To address this, laser-assisted in situ keratomileusis (LASIK) has been adapted with advanced techniques such as the Supracor and PresbyMax algorithms, which modify corneal topography by creating a central elevation for near vision and a flatter periphery for intermediate and distance vision. We aimed to evaluate the effectiveness and safety of Supracor LASIK in improving both near and distance vision. Patients and methods A prospective controlled clinical trial was conducted, involving 30 eyes treated with Supracor refractive surgery. Preoperative and postoperative assessments were performed to measure visual outcomes. Results Postoperative evaluations revealed significant enhancements in distance vision for both dominant and nondominant eyes, as well as improved binocular near and distance visual acuity. A small percentage of nondominant eyes experienced slight vision loss (3.3% lost two lines, 13.3% lost one line), while no such decline was observed in dominant eyes. Patient satisfaction was favorable, with average scores of 2.73±1.20 for near vision and 4.40±0.62 for distance vision without glasses. Conclusion Supracor LASIK is an effective option for hyperopic patients with presbyopia. Successful outcomes depend on thorough preoperative assessment and personalized treatment planning, considering the patient’s adaptability to monovision. Proper patient counseling regarding potential risks, such as minor vision loss or the need for enhancements, is essential.